Cyclic Nucleotide Phosphodiesterase Activity, Expression, and Targeting in Cells of the Cardiovascular System
- 1 September 2003
- journal article
- review article
- Published by Elsevier in Molecular Pharmacology
- Vol. 64 (3) , 533-546
- https://doi.org/10.1124/mol.64.3.533
Abstract
Cyclic AMP (cAMP) and cGMP regulate a myriad of cellular functions, such as metabolism, contractility, motility, and transcription in virtually all cell types, including those of the cardiovascular system. Considerable effort over the last 20 years has allowed identification of the cellular components involved in the synthesis of cyclic nucleotides, as well as effectors of cyclic nucleotide-mediated signaling. More recently, a central role for cyclic nucleotide phosphodiesterase (PDE) has also been elaborated in many cell types, including those involved in regulating the activities of the cardiovascular system. In this review, we introduce the PDE families whose members are expressed in cells of the cardiovascular system including cardiomyocytes, vascular smooth muscle cells, and vascular endothelial cells. Because cell behavior is a dynamic process influenced by numerous factors, we will attempt to emphasize how changes in the activity, expression, and targeting of PDE influence cyclic nucleotide-mediated regulation of the behavior of these cells.Keywords
This publication has 100 references indexed in Scilit:
- A phosphatidylinositol 3-kinase–phosphodiesterase 3B–cyclic AMP pathway in hypothalamic action of leptin on feedingNature Neuroscience, 2002
- Suppression of arterial intimal hyperplasia by cilostamide, a cyclic nucleotide phosphodiesterase 3 inhibitor, in a rat balloon double‐injury modelBritish Journal of Pharmacology, 2000
- The Guanylyl Cyclase ReceptorsMethods, 1999
- Identification of cGMP-Dependent Protein Kinase Anchoring Proteins (GKAPs)Biochemical and Biophysical Research Communications, 1998
- Modulation of cell adhesion molecule expression and function on human lung microvascular endothelial cells by inhibition of phosphodiesterases 3 and 4British Journal of Pharmacology, 1998
- Altered Expression of PDE1 and PDE4 Cyclic Nucleotide Phosphodiesterase Isoforms in 7-oxo-prostacyclin-preconditioned Rat HeartJournal of Molecular and Cellular Cardiology, 1997
- Calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1C) is induced in human arterial smooth muscle cells of the synthetic, proliferative phenotype.Journal of Clinical Investigation, 1997
- An Essential Aspartic Acid at Each of Two Allosteric cGMP-binding Sites of a cGMP-specific PhosphodiesterasePublished by Elsevier ,1995
- A Novel Cyclic GMP Stimulated Phosphodiesterase from Rat BrainBiochemical and Biophysical Research Communications, 1994
- Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitorsTrends in Pharmacological Sciences, 1990